Two New CME Modules Added to the European Obesity Initiative on

Tunbridge Wells, United Kingdom, April 03, 2015 --( Today, two new modules have been added to the EACCME-accredited European Obesity Initiative Continuing Medical Education (CME) series on, the website for healthcare professionals. The modules are free to access and worth a combined total of 3 European CME credits (ECMECs).

Globally, there are more than 1.9 billion overweight adults, of whom at least 600 million are clinically obese.1 Obesity is a complex condition associated with increased risk of numerous diseases, including type 2 diabetes, hypertension, stroke, cardiovascular disease, osteoarthritis and cancers. It also has serious social and psychological consequences, such as low self-esteem and clinical depression, which can affect people of all ages. It is therefore essential that healthcare professionals are provided with the latest information about obesity so that they can support their patients in instigating and maintaining a healthy lifestyle.

The new CME modules follow on from the first in the series, "Understanding Obesity," which examined participants about obesity as a serious medical illness, its complications, and how to develop an effective weight-management strategy. Module 2 "Considerations for Individualising Pharmacotherapy" focuses on the complexities of obesity, the appropriate use of pharmacotherapy for weight management, and how to individualise patient care. Module 3 "Rationale for Lifelong Behaviour Change" explores the factors affecting weight loss maintenance, the importance of implementing lifelong behaviour changes to prevent weight regain, and the components of a successful long-term weight management strategy. All three modules are available with accreditation statements from EACCME at

“We are pleased to host this series of obesity CME activities, designed by apothecom – one of our medical communications partners – and funded through an educational grant from Novo Nordisk. It adds valuable support for our members to effectively manage their patients who are overweight or obese,” said Dr Toby Galbraith, Director of Content Strategy for EPG Health Media.

For further information please contact:

Kristie Marchant (Community Manager, EPG Health Media)

Royal Victoria House
51-55 The Pantiles
Tunbridge Wells
Kent TN2 5TE
United Kingdom

Tel: 01892 526776

Notes to Editors:
· Published by EPG Health Media (Europe) Ltd., is an independent website dedicated to providing healthcare professionals with free access to the most recent, best-practice diagnosis and patient management guidance. In addition to the library of disease Knowledge Centres, the website includes a database of prescription drugs in nine European languages, clinical trial reports, treatment guidelines, medical news, journal abstracts, multimedia, and apps; all arranged around 48 disease topic areas.

· Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 38,000 employees in 75 countries, and markets its products in more than 180 countries.

· apothecom is a leading global medical communications agency providing multi-platform medical communications and publication planning services to a host of pharma and biotech clients. apothecom is a member of the Huntsworth Health group.

· An accreditation statement has been supplied by the European Accreditation Council for Continuing Medical Education (EACCME) for each of the three CME modules. These are available at

1. World Health Organization. Obesity and Overweight Fact sheet No 311. January 2015. Available at: (Accessed 22 January 2015)
EPG Health Media
Kristie Marchant
01892 526 776